Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.

Related Articles
Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.
J Clin Psychopharmacol. 2018 Oct 16;:
Authors: S…

read more

The mediating effect of family function and medication adherence between symptoms and mental disability among Chinese patients with schizophrenia: a cross-sectional study.

Related Articles
The mediating effect of family function and medication adherence between symptoms and mental disability among Chinese patients with schizophrenia: a cross-sectional study.
Psychol Health Med. 2018 Oct 17;:1-…

read more

Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia.

Related Articles
Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia.
Cochrane Database Syst Rev. 2018 Oct 05;10:CD012398
Authors: Morris K, Reid G, Spencer S

read more

Medication state at the time of the offense: Medication noncompliance, insight and criminal responsibility.

Related Articles
Medication state at the time of the offense: Medication noncompliance, insight and criminal responsibility.
Behav Sci Law. 2018 May;36(3):339-357
Authors: Parrott CT, Jones MA, Brodsky SL, Shealy C…

read more

Adherence, insight and disability in paranoid schizophrenia.

Related Articles
Adherence, insight and disability in paranoid schizophrenia.
Psychiatry Res. 2018 Sep 23;270:274-280
Authors: García-Cabeza I, Díaz-Caneja CM, Ovejero M, de Portugal E
Abstract
Insig…

read more

Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics.

Related Articles
Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics.
Adv Ther. 2018 Sep 29;:
Authors: Shah A, X…

read more

Barriers to using clozapine in treatment-resistant schizophrenia: systematic review.

Related Articles
Barriers to using clozapine in treatment-resistant schizophrenia: systematic review.
BJPsych Bull. 2018 Sep 28;:1-9
Authors: Farooq S, Choudry A, Cohen D, Naeem F, Ayub M
Abstract
Ai…

read more

Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia.

Related Articles
Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia.
S Afr J Psychiatr. 2018;24:1124
Authors: Tareke M, Tesfaye S, Amare D, Belete T, Abate A
Abstract

read more

Barriers to the implementation of a computer-based rehabilitation programme in two public psychiatric settings.

Related Articles
Barriers to the implementation of a computer-based rehabilitation programme in two public psychiatric settings.
S Afr J Psychiatr. 2018;24:1163
Authors: Ferreira-Correia A, Barberis T, Msimanga L

read more

Validation study of the Brief Medication Adherence Scale (BMAS) in patients with schizophrenia and related disorders in Hong Kong.

Related Articles
Validation study of the Brief Medication Adherence Scale (BMAS) in patients with schizophrenia and related disorders in Hong Kong.
Asian J Psychiatr. 2018 Sep 12;37:154-160
Authors: Chui E, Wong KL,…

read more
Page 1 of 13612345»102030...Last »